Skip to main content
. Author manuscript; available in PMC: 2016 Oct 5.
Published in final edited form as: Leukemia. 2016 Apr 5;30(8):1682–1690. doi: 10.1038/leu.2016.70

Fig. 2. BMI1 silencing enhances imatinib-induced inhibition of cell proliferation and colony formation of BV173 cells.

Fig. 2

(A) Western blot shows BMI1 expression in imatinib (IM)- or Doxy-treated shBMI1 BV173 cells; (B) cell counts at 168h post treatment or (C) colony formation of untreated shBMI1 BV173 cells or cells treated with Doxy (2.5μg/ml), IM (1μM), or the Doxy/IM combination. Data represent the mean + SD of three independent experiments. Statistical analysis: one way Anova with Bonferroni’s correction. *<0.05.